Authors
Latest:
Investigating the Impact of Intervention Refusal on Hospital ReadmissionFindings suggest that some at-risk patients may not be receptive to in-home transition interventions and that opting out may be associated with higher odds of hospital readmission.
Latest:
Race/Ethnicity, Personal Health Record Access, and Quality of CareQuality benefits were equal across racial/ethnic groups with equal personal health record (PHR) use, but nonwhite status and a preference for Spanish language predicted lower PHR registration.
Latest:
Outpatient-Shopping Behavior and Survival Rates in Newly Diagnosed Cancer PatientsHigher incomes, higher comorbidity scores, and more advanced cancer were associated with outpatient-shopping behavior in Taiwanese patients.
Latest:
Health Insurance and Breast-Conserving Surgery With Radiation TreatmentType of health insurance plays a significant role in the likelihood of receiving the recommended treatment among women diagnosed with early-stage breast cancer.
Latest:
Utilization of Lymph Node Dissection, Race/Ethnicity, and Breast Cancer OutcomesThe disparities in survival among node-positive breast cancer patients of African American and Hispanic heritage are not explained by nodal surgery utilization.
Latest:
Cost Analysis Review of Stroke Centers, Telestroke, and rt-PAUse of rt-PA is associated with long-term cost savings, but more high-quality, current cost-effectiveness research is needed for stroke centers, care networks, and telemedicine.
Latest:
Gatekeeping and Patterns of Outpatient Care Post Healthcare ReformIs specialist “gatekeeping” in modern health maintenance organization (HMO) insurance associated with differences in outpatient care? The study finds that HMO gatekeeping may meaningfully reduce specialist utilization.
Latest:
Cardio-Oncology: The Intersection Between Cancer and Cardiovascular DiseaseWith the prognosis for many cancers improving, we are seeing an appropriate sharpening of focus on the cardiovascular risks of patients who have survived cancer or are being treated for cancer, as well as a growing recognition of the impact this competing morbidity has on both short- and long-term health outcomes.
Latest:
Timing of Follow-up After Abnormal Screening and Diagnostic MammogramsWoman-level characteristics such as breast symptoms at mammography are associated with earlier follow-up within an integrated health system with an active breast health plan.
Latest:
Value and the Medical Home: Effects of Transformed Primary CareA patient-centered medical home with intensive case management and a payer partner can significantly improve hospital utilization and may decrease total medical costs for a Medicare population.
Latest:
Testing Novel Patient Financial Incentives to Increase Breast Cancer ScreeningThis study tested 3 financial incentives encouraging breast cancer screening (mammograms) among women deemed overdue. None were effective overall; "person-centered" incentives worked in the most recently screened subgroup.
Latest:
Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular EventsUse of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.
Latest:
Association Among Change in Medical Costs, Level of Comorbidity, and Change in Adherence BehaviorThe authors found that comorbidity burden and the direction of behavioral change influence the relationship between adherence and medical spend. This could affect the cost-benefit considerations of medication adherence programs.
Latest:
Triathlete Pushes Limits of What's Possible With Type 1 DiabetesA former triathlete and a T1DM patient, Jay Hewitt, was the special guest speaker at the PCDC 2014 meeting.
Latest:
Impact of Cost-Sharing on Treatment Augmentation in Patients With DepressionHigher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
